annual accounts payable:
$8.53M-$1.71M(-16.67%)Summary
- As of today (June 17, 2025), NAGE annual accounts payable is $8.53 million, with the most recent change of -$1.71 million (-16.67%) on December 1, 2024.
- During the last 3 years, NAGE annual accounts payable has fallen by -$1.90 million (-18.20%).
- NAGE annual accounts payable is now -18.20% below its all-time high of $10.42 million, reached on December 1, 2021.
Performance
NAGE Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$10.63M+$2.11M(+24.70%)Summary
- As of today (June 17, 2025), NAGE quarterly accounts payable is $10.63 million, with the most recent change of +$2.11 million (+24.70%) on March 1, 2025.
- Over the past year, NAGE quarterly accounts payable has increased by +$2.73 million (+34.60%).
- NAGE quarterly accounts payable is now -9.07% below its all-time high of $11.69 million, reached on March 1, 2021.
Performance
NAGE quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NAGE Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -16.7% | +34.6% |
3 y3 years | -18.2% | +8.7% |
5 y5 years | -11.4% | +30.3% |
NAGE Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -18.2% | at low | at high | +54.0% |
5 y | 5-year | -18.2% | at low | -9.1% | +54.5% |
alltime | all time | -18.2% | >+9999.0% | -9.1% | >+9999.0% |
NAGE Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $10.63M(+24.7%) |
Dec 2024 | $8.53M(-16.7%) | $8.53M(+23.5%) |
Sep 2024 | - | $6.90M(-14.8%) |
Jun 2024 | - | $8.11M(+2.6%) |
Mar 2024 | - | $7.90M(-22.8%) |
Dec 2023 | $10.23M(+5.7%) | $10.23M(+11.2%) |
Sep 2023 | - | $9.20M(-8.3%) |
Jun 2023 | - | $10.03M(+12.1%) |
Mar 2023 | - | $8.95M(-7.5%) |
Dec 2022 | $9.68M(-7.1%) | $9.68M(+6.1%) |
Sep 2022 | - | $9.12M(-10.6%) |
Jun 2022 | - | $10.20M(+4.3%) |
Mar 2022 | - | $9.78M(-6.2%) |
Dec 2021 | $10.42M(+10.4%) | $10.42M(-3.5%) |
Sep 2021 | - | $10.80M(+8.4%) |
Jun 2021 | - | $9.97M(-14.7%) |
Mar 2021 | - | $11.69M(+23.8%) |
Dec 2020 | $9.45M(-1.9%) | $9.45M(+37.3%) |
Sep 2020 | - | $6.88M(-29.6%) |
Jun 2020 | - | $9.78M(+19.9%) |
Mar 2020 | - | $8.16M(-15.2%) |
Dec 2019 | $9.63M(+0.8%) | $9.63M(+56.1%) |
Sep 2019 | - | $6.17M(-33.8%) |
Jun 2019 | - | $9.32M(-4.4%) |
Mar 2019 | - | $9.75M(+2.1%) |
Dec 2018 | $9.55M(+156.7%) | $9.55M(+7.4%) |
Sep 2018 | - | $8.89M(+31.6%) |
Jun 2018 | - | $6.76M(+15.4%) |
Mar 2018 | - | $5.86M(+57.5%) |
Dec 2017 | $3.72M(-37.8%) | $3.72M(-14.4%) |
Sep 2017 | - | $4.35M(+38.8%) |
Jun 2017 | - | $3.13M(-60.2%) |
Mar 2017 | - | $7.87M(+31.6%) |
Dec 2016 | $5.98M | $5.98M(+45.9%) |
Sep 2016 | - | $4.10M(+75.8%) |
Jun 2016 | - | $2.33M(-19.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2016 | - | $2.91M(-53.3%) |
Dec 2015 | $6.22M(+80.3%) | $6.22M(+74.8%) |
Sep 2015 | - | $3.56M(+15.1%) |
Jun 2015 | - | $3.09M(+17.2%) |
Mar 2015 | - | $2.64M(-23.5%) |
Dec 2014 | $3.45M(+139.5%) | $3.45M(+52.0%) |
Sep 2014 | - | $2.27M(-17.7%) |
Jun 2014 | - | $2.76M(+43.5%) |
Mar 2014 | - | $1.92M(+33.4%) |
Dec 2013 | $1.44M(-58.0%) | $1.44M(-38.6%) |
Sep 2013 | - | $2.35M(+9.1%) |
Jun 2013 | - | $2.15M(-9.4%) |
Mar 2013 | - | $2.38M(-30.7%) |
Dec 2012 | $3.43M(+52.4%) | $3.43M(+20.8%) |
Sep 2012 | - | $2.84M(-16.5%) |
Jun 2012 | - | $3.40M(+10.9%) |
Mar 2012 | - | $3.07M(+36.3%) |
Dec 2011 | $2.25M(+337.3%) | $2.25M(+72.2%) |
Sep 2011 | - | $1.31M(-3.7%) |
Jun 2011 | - | $1.36M(+38.4%) |
Mar 2011 | - | $980.60K(+90.6%) |
Dec 2010 | $514.60K(-6.1%) | $514.60K(-36.9%) |
Sep 2010 | - | $815.60K(+3.6%) |
Jun 2010 | - | $786.90K(-10.4%) |
Mar 2010 | - | $878.60K(+60.2%) |
Dec 2009 | $548.30K(+23.4%) | $548.30K(+15.8%) |
Sep 2009 | - | $473.60K(-2.6%) |
Jun 2009 | - | $486.30K(-2.4%) |
Mar 2009 | - | $498.20K(+12.1%) |
Dec 2008 | $444.30K(>+9900.0%) | $444.30K(+14.2%) |
Sep 2008 | - | $389.00K(-28.9%) |
Jun 2008 | - | $547.50K(>+9900.0%) |
Feb 2008 | - | $3300.00(+725.0%) |
Nov 2007 | $400.00 | $400.00(-20.0%) |
Aug 2007 | - | $500.00(0.0%) |
May 2007 | - | $500.00(0.0%) |
Feb 2007 | - | $500.00 |
FAQ
- What is Niagen Bioscience annual accounts payable?
- What is the all time high annual accounts payable for Niagen Bioscience?
- What is Niagen Bioscience annual accounts payable year-on-year change?
- What is Niagen Bioscience quarterly accounts payable?
- What is the all time high quarterly accounts payable for Niagen Bioscience?
- What is Niagen Bioscience quarterly accounts payable year-on-year change?
What is Niagen Bioscience annual accounts payable?
The current annual accounts payable of NAGE is $8.53M
What is the all time high annual accounts payable for Niagen Bioscience?
Niagen Bioscience all-time high annual accounts payable is $10.42M
What is Niagen Bioscience annual accounts payable year-on-year change?
Over the past year, NAGE annual accounts payable has changed by -$1.71M (-16.67%)
What is Niagen Bioscience quarterly accounts payable?
The current quarterly accounts payable of NAGE is $10.63M
What is the all time high quarterly accounts payable for Niagen Bioscience?
Niagen Bioscience all-time high quarterly accounts payable is $11.69M
What is Niagen Bioscience quarterly accounts payable year-on-year change?
Over the past year, NAGE quarterly accounts payable has changed by +$2.73M (+34.60%)